174 related articles for article (PubMed ID: 11084687)
21. Correction of dog dystrophic epidermolysis bullosa by transplantation of genetically modified epidermal autografts.
Gache Y; Pin D; Gagnoux-Palacios L; Carozzo C; Meneguzzi G
J Invest Dermatol; 2011 Oct; 131(10):2069-78. PubMed ID: 21697889
[TBL] [Abstract][Full Text] [Related]
22. Gene therapy approaches for epidermolysis bullosa.
Ferrari S; Pellegrini G; Mavilio F; De Luca M
Clin Dermatol; 2005; 23(4):430-6. PubMed ID: 16023940
[TBL] [Abstract][Full Text] [Related]
23. Early intra-amniotic gene transfer using lentiviral vector improves skin blistering phenotype in a murine model of Herlitz junctional epidermolysis bullosa.
Endo M; Zoltick PW; Radu A; Jiang Q; Matsui C; Marinkovich PM; McGrath J; Tamai K; Uitto J; Flake AW
Gene Ther; 2012 May; 19(5):561-9. PubMed ID: 21938019
[TBL] [Abstract][Full Text] [Related]
24. Sustained phenotypic reversion of junctional epidermolysis bullosa dog keratinocytes: Establishment of an immunocompetent animal model for cutaneous gene therapy.
Spirito F; Capt A; Del Rio M; Larcher F; Guaguere E; Danos O; Meneguzzi G
Biochem Biophys Res Commun; 2006 Jan; 339(3):769-78. PubMed ID: 16316622
[TBL] [Abstract][Full Text] [Related]
25. Long-term engraftment of single genetically modified human epidermal holoclones enables safety pre-assessment of cutaneous gene therapy.
Larcher F; Dellambra E; Rico L; Bondanza S; Murillas R; Cattoglio C; Mavilio F; Jorcano JL; Zambruno G; Del Rio M
Mol Ther; 2007 Sep; 15(9):1670-6. PubMed ID: 17579576
[TBL] [Abstract][Full Text] [Related]
26. Genetic correction of inherited epidermal disorders.
Khavari PA
Hum Gene Ther; 2000 Nov; 11(16):2277-82. PubMed ID: 11084686
[TBL] [Abstract][Full Text] [Related]
27. In vivo transduction of mouse epidermis with recombinant retroviral vectors: implications for cutaneous gene therapy.
Ghazizadeh S; Harrington R; Taichman L
Gene Ther; 1999 Jul; 6(7):1267-75. PubMed ID: 10455435
[TBL] [Abstract][Full Text] [Related]
28. Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa.
Tolar J; Xia L; Lees CJ; Riddle M; McElroy A; Keene DR; Lund TC; Osborn MJ; Marinkovich MP; Blazar BR; Wagner JE
J Invest Dermatol; 2013 Feb; 133(2):562-5. PubMed ID: 22931927
[No Abstract] [Full Text] [Related]
29. A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa.
Zwicklhuber J; Kocher T; Liemberger B; Hainzl S; Bischof J; Strunk D; Raninger AM; Gratz I; Wally V; Guttmann-Gruber C; Hofbauer JP; Bauer JW; Koller U
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982270
[TBL] [Abstract][Full Text] [Related]
30. Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations.
Kwong A; Cogan J; Hou Y; Antaya R; Hao M; Kim G; Lincoln V; Chen Q; Woodley DT; Chen M
Mol Ther; 2020 May; 28(5):1327-1338. PubMed ID: 32222156
[TBL] [Abstract][Full Text] [Related]
31. Lack of K140 immunoreactivity in junctional epidermolysis bullosa skin and keratinocytes associates with misfolded laminin epidermal growth factor-like motif 2 of the β3 short arm.
Condorelli AG; Fortugno P; Cianfarani F; Proto V; Di Zenzo G; Didona B; Zambruno G; Castiglia D
Br J Dermatol; 2018 Jun; 178(6):1416-1422. PubMed ID: 28561256
[TBL] [Abstract][Full Text] [Related]
32. Toward Combined Cell and Gene Therapy for Genodermatoses.
De Rosa L; Latella MC; Secone Seconetti A; Cattelani C; Bauer JW; Bondanza S; De Luca M
Cold Spring Harb Perspect Biol; 2020 May; 12(5):. PubMed ID: 31653644
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of prenatal intra-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease.
Mühle C; Neuner A; Park J; Pacho F; Jiang Q; Waddington SN; Schneider H
Gene Ther; 2006 Dec; 13(23):1665-76. PubMed ID: 16871230
[TBL] [Abstract][Full Text] [Related]
34. SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa.
Titeux M; Pendaries V; Zanta-Boussif MA; Décha A; Pironon N; Tonasso L; Mejia JE; Brice A; Danos O; Hovnanian A
Mol Ther; 2010 Aug; 18(8):1509-18. PubMed ID: 20485266
[TBL] [Abstract][Full Text] [Related]
35. Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes.
Kolodka TM; Garlick JA; Taichman LB
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4356-61. PubMed ID: 9539741
[TBL] [Abstract][Full Text] [Related]
36. Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants.
Mosallaei D; Hao M; Antaya RJ; Levian B; Kwong A; Cogan J; Hamilton C; Schwieger-Briel A; Tan C; Tang X; Woodley DT; Chen M
JAMA Dermatol; 2022 Apr; 158(4):366-374. PubMed ID: 35234826
[TBL] [Abstract][Full Text] [Related]
37. Defective integrin alpha 6 beta 4 expression in the skin of patients with junctional epidermolysis bullosa and pyloric atresia.
Brown TA; Gil SG; Sybert VP; Lestringant GG; Tadini G; Caputo R; Carter WG
J Invest Dermatol; 1996 Sep; 107(3):384-91. PubMed ID: 8751975
[TBL] [Abstract][Full Text] [Related]
38. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
Gache Y; Baldeschi C; Del Rio M; Gagnoux-Palacios L; Larcher F; Lacour JP; Meneguzzi G
Hum Gene Ther; 2004 Oct; 15(10):921-33. PubMed ID: 15585108
[TBL] [Abstract][Full Text] [Related]
39. Establishment and characterization of cell line LSV5 that retains the altered adhesive properties of human junctional epidermolysis bullosa keratinocytes.
Miquel C; Gagnoux-Palacios L; Durand-Clement M; Marinkovich P; Ortonne JP; Meneguzzi G
Exp Cell Res; 1996 May; 224(2):279-90. PubMed ID: 8612705
[TBL] [Abstract][Full Text] [Related]
40. Virus-mediated gene transfer for cutaneous gene therapy.
Ghazizadeh S; Taichman LB
Hum Gene Ther; 2000 Nov; 11(16):2247-51. PubMed ID: 11084682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
